|Videos|April 1, 2021
Role of Bevacizumab for Initial Therapy in Advanced Ovarian Cancer
Author(s)Rebecca Previs, MD
An expert in gynecologic oncology talks about the role of bevacizumab in the front-line management of advanced ovarian cancer.
Advertisement
Advertisement
Related to this article
The European Medicines Agency’s CHMP recommended approval of relacorilant plus nab-paclitaxel for platinum-resistant ovarian cancer based on the ROSELLA trial.
Advertisement
Advertisement
Trending on CancerNetwork
1
CELMoDs After T-Cell–Engaging Therapy in Multiple Myeloma
2
Key Takeaways for Multidisciplinary Lung Cancer Care From WCLC 2026
3
Neoantigen Vaccine Shows Encouraging Activity in Head and Neck Cancer
4
What Were the Key Hematologic Oncology Takeaways from SOHO 2026?
5